内部控制有效性与企业创新投入——来自上市公司内部控制缺陷披露的证据  

The Effectiveness of Internal Control and Enterprise Innovation Investment——Empirical Evidence from the Disclosure of the Internal Control Weaknesses in Listed Companies

作　　者：倪静洁[1] 吴秋生[1] NI Jing-jie;WU Qiu-sheng(School of Accounting,Shanxi University of Finance and Economics,Taiyuan 030006,China)

机构地区：[1]山西财经大学会计学院,山西太原030006

出　　处：《山西财经大学学报》2020年第9期70-84,共15页Journal of Shanxi University of Finance and Economics

基　　金：国家自然科学基金面上项目(71872105);山西省高等学校哲学社会科学研究项目(2019W069);山西省“1331工程”重点创新团队建设计划(晋教科[2017]12号)。

摘　　要：从"缺陷有效观"出发,以内部控制是否存在重大缺陷判定其有效性,选取2012—2018年的中国A股上市公司作为研究样本,考察了内部控制有效性及其不同维度的特征对企业创新投入的影响。研究结果表明:存在重大缺陷的内部控制不利于企业增加创新投入,且重大缺陷累计出现的次数越多,对企业创新投入的不利影响就越大;相较于业务层面的内部控制重大缺陷,公司层面的内部控制重大缺陷对企业创新投入的负面影响更大。进一步的研究显示,内部控制重大缺陷通过恶化两类代理问题抑制企业的创新投入,而企业所处地区的监督环境越好,两者的负向关系就越弱。Based on the view of"devect validity",this paper used the existence of internal control material weaknesses(ICMW)to test its effectiveness,and selected A-share listed companies from 2012 to 2018 as research samples,then investigated the influence of the effectiveness of internal control and its’characteristics on innovation investment.The research showed that,the internal control with ICMW was not conducive to enterprise innovation investment,and the larger accumulated number of ICMW had a greater negative effect.Compared with the ICMW at business level,the ICMW at company level also had a greater negative effect on innovation investment.Further research revealed that,ICMW restricted enterprise innovation investment by worsening the two kinds of agency problems.However,the enterprises with better supervision environment could weaken the negative relationship.

关 键 词：内部控制有效性 内部控制重大缺陷 创新投入 代理问题 监督环境 

分 类 号：F230[经济管理—会计学]